about
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, ...
Read More
20.72
-0.61
(-2.86%)
178.4K
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Tourmaline Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..